Molecular Modeling Market Report 2026

The molecular modeling market size has grown rapidly in recent years. It will grow from $9.44 billion in 2025 to $10.89 billion in 2026 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to growing reliance on computational drug design, increasing academic research output, rising adoption of molecular mechanics tools, high demand for 3D visualization solutions, technological limitations in earlier modeling systems.

The molecular modeling market size is expected to see rapid growth in the next few years. It will grow to $20.08 billion in 2030 at a compound annual growth rate (CAGR) of 16.5%. The growth in the forecast period can be attributed to expansion of ai-based predictive modeling, increasing pharmaceutical investment in simulation tools, growing cloud computing integration, rising need for accelerated drug discovery, development of quantum chemistry capabilities. Major trends in the forecast period include integration of AI-driven molecular simulation tools, adoption of cloud-based modeling platforms, enhanced automation in computational chemistry workflows, increased use of ar/vr interfaces for structural visualization, growth in precision-based predictive modeling techniques.

The growing adoption of personalized medicine is expected to drive the growth of the molecular modeling market in the coming years. Personalized medicine is a healthcare approach that tailors treatments and medical decisions to individual patients based on their unique genetic, molecular, and clinical characteristics. Molecular modeling plays a key role in personalized medicine by predicting patient responses to therapies, designing tailored drug treatments, and optimizing treatment regimens according to molecular profiles. For example, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and healthcare organization, the FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six in 2022. Therefore, the rise of personalized medicine is fueling the growth of the molecular modeling market.

Key companies in the molecular modeling market are developing innovative technologies, such as molecular modeling platforms, to better serve existing and new customers. A molecular modeling platform is a software suite that provides tools for visualization, simulation, and molecular analysis. For instance, in August 2023, Cresset Group, a UK-based provider of drug discovery solutions, launched Flare V7, an advanced drug design platform. Flare V7 integrates ligand- and structure-based approaches to facilitate more effective small-molecule discovery. It offers ensemble docking, reinforcement of Quantum Mechanics (QM) and Quantitative Structure-Activity Relationship (QSAR) methodologies, and a range of tools for troubleshooting Free Energy Perturbation (FEP) experiments, analyzing dynamics trajectories, and preparing ligand structures for detailed studies, representing a significant advancement in molecular modeling capabilities.

In May 2023, Recursion Pharmaceuticals, a US-based clinical-stage biotechnology company, acquired Valence Discovery Inc. for an undisclosed sum. This acquisition strengthens Recursion’s molecular modeling capabilities by integrating Valence’s AI-driven chemistry engine and accelerating its digital chemistry workflows for drug discovery. Valence Discovery Inc., based in Canada, specializes in advanced molecular modeling and predictive chemistry solutions using artificial intelligence (AI) and machine learning (ML).

Major companies operating in the molecular modeling market are Thermo Fisher Scientific Inc., Dassault Systemes SE, Bruker Corporation, Physiomics plc, SilcsBio LLC, Certara Inc., Schrödinger Inc., Jubilant Biosys Ltd., Simulations Plus Inc., Genedata AG, Acellera Ltd., Advanced Chemistry Development Inc., Molsoft L.L.C., OTAVA Ltd., Chemical Computing Group, Optibrium Ltd., BioSolveIT GmbH, Cyclica Inc., Cresset Group, Cyrus Biotechnology Inc., 3D Molecular Designs LLC, Leadscope Inc.

North America was the largest region in the molecular modeling market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular modeling market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the molecular modeling market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs on software imports, high-performance computing hardware, and cloud-based IT infrastructure have led to increased operational costs for molecular modeling platforms, particularly impacting research institutions and biotechnology companies in regions dependent on imported computational systems. Software and service segments experience the greatest tariff-related cost fluctuations. On the positive side, tariffs encourage local development of modeling software and data centers, strengthening regional technological self-reliance in the long term.

The molecular modeling market research report is one of a series of new reports that provides molecular modeling market statistics, including molecular modeling industry global market size, regional shares, competitors with a molecular modeling market share, detailed molecular modeling market segments, market trends and opportunities, and any further data you may need to thrive in the molecular modeling industry. This molecular modeling market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Molecular modeling refers to the creation, visualization, and manipulation of three-dimensional structures of chemical and biological molecules, as well as the determination of their physicochemical properties to understand the structural activity relationship (SAR) of these molecules. It uses computer programs and mathematical algorithms to predict and display the three-dimensional structure and characteristics of molecules.

The main products in molecular modeling include software and services. Software consists of instructions, data, and programs that allow a computer or computing device to perform specific tasks, solve problems, or execute operations. The approaches used include molecular mechanics and quantum chemistry, applied in drug discovery, drug development, and other related fields. The end users include pharmaceutical and biotechnology companies, research centers, academic institutions, and others.

The molecular modeling market consists of revenues earned by entities by providing services such as molecular modeling consultancy services, computational chemistry services, receptor-based and ligand-based virtual screening, and in silico screening and molecular modeling services. The market value includes the value of related goods sold by the service provider or included within the service offering. The molecular modeling market also includes sales of protein modeling and drug discovery tools, cheminformatics and computational chemistry databases, and visualization and molecular graphics tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.